Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Nasdaq had flagged Liminatus Pharma on Jan. 15, 2026 for 30 straight business days below $1.00. After a 1-for-50 reverse split effective Aug. 20, 2026, Nasdaq confirmed compliance based on 13 consecutive sessions above $1.00 from Aug. 21 to Sept. 9, and moved the shares to the Nasdaq Capital Market effective Aug. 4 wit
Liminatus Pharma, Inc. regained compliance with Nasdaq’s minimum bid price rule after effecting a 1-for-50 reverse stock split on Aug. 20, 2026. Nasdaq confirmed the bid stayed above $1 for 13 consecutive trading days ending Sept. 9, 2026.Material DetailsContext by AI AnalystThis is a late confirma…
FULLERTON, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. NASDAQ:LIMN (“Liminatus” or the “Company”) today announced that the Company has regained compliance with Nasdaq’s minimum bid price rule.As previously disclosed, on January 15, 2026 the Company received a notice from Nasda…